Kai-Zhou Jin (Kaizhou Jin)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Combination Therapy

Transcription Factor

Genome Wide Analysis

Top Venues

Cell death & disease

This page only lists publications with an associated author ORCID identifier.

Publications

Hui-Ru Zhang, Tian-Jiao Li, Xian-Jun Yu, Chen Liu, Wei-Ding Wu, Long-Yun Ye, Kai-Zhou Jin
The GFPT2-O-GlcNAcylation-YBX1 axis promotes IL-18 secretion to regulate the tumor immune microenvironment in pancreatic cancer. Cell death & disease 15 (4) (2024)
Hui-Ru Zhang, Tian-Jiao Li, Xian-Jun Yu, Chen Liu, Wei-Ding Wu, Long-Yun Ye, Kai-Zhou Jin
The GFPT2-O-GlcNAcylation-YBX1 axis promotes IL-18 secretion to regulate the tumor immune microenvironment in pancreatic cancer. Cell death & disease 15 (4) (2024)
Hui-Ru Zhang, Tian-Jiao Li, Xian-Jun Yu, Chen Liu, Wei-Ding Wu, Long-Yun Ye, Kai-Zhou Jin
The GFPT2-O-GlcNAcylation-YBX1 axis promotes IL-18 secretion to regulate the tumor immune microenvironment in pancreatic cancer. Cell death & disease 15 (4) (2024)
Hui-Ru Zhang, Tian-Jiao Li, Xian-Jun Yu, Chen Liu, Wei-Ding Wu, Long-Yun Ye, Kai-Zhou Jin
The GFPT2-O-GlcNAcylation-YBX1 axis promotes IL-18 secretion to regulate the tumor immune microenvironment in pancreatic cancer. Cell death & disease 15 (4) (2024)
Saimeng Shi, Duancheng Guo, Longyun Ye, Tianjiao Li, Qing-Lin Fei, Mengxiong Lin, Xian-Jun Yu, Kai-Zhou Jin, Wei-Ding Wu
Knockdown of TACC3 inhibits tumor cell proliferation and increases chemosensitivity in pancreatic cancer. Cell death & disease 14 (11) (2023)